Search Results - "Balashov, K."

Refine Results
  1. 1
  2. 2
  3. 3

    Seasonal prevalence of MS disease activity by MEIER, D. S, BALASHOV, K. E, HEALY, B, WEINER, H. L, GUTTMANN, C. R. G

    Published in Neurology (31-08-2010)
    “…This observational cohort study investigated the seasonal prevalence of multiple sclerosis (MS) disease activity (likelihood and intensity), as reflected by…”
    Get full text
    Journal Article
  4. 4

    Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis by Valenzuela, R.M, Kaufman, M, Balashov, K.E, Ito, K, Buyske, S, Dhib-Jalbut, S

    Published in Journal of neuroimmunology (15-11-2016)
    “…Abstract A prospective study of 62 patients with relapsing-remitting multiple sclerosis (RRMS) treated with Glatiramer acetate (GA) was conducted to evaluate…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Optimized calculator for a qualitative risk assessment of osteoporotic fractures for the population of Moscow by Artyukova, Zlata R., Kudryavtsev, Nikita D., Ikryannikov, Egor O., Titova, Anna V., Balashov, Maksim K., Petraikin, Alexey V.

    Published in Digital diagnostics (26-06-2023)
    “…BACKGROUND: The FRAX tool (a 10-year fracture risk assessment) is recommended to diagnose osteoporosis and optimize the number of patients who need to undergo…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Seasonal variation of interferon-gamma production in progressive multiple sclerosis by Balashov, K E, Olek, M J, Smith, D R, Khoury, S J, Weiner, H L

    Published in Annals of neurology (01-11-1998)
    “…Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. There is increased interferon (IFN)-gamma secretion in MS patients in…”
    Get more information
    Journal Article
  9. 9

    Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia by Smith, D R, Balashov, K E, Hafler, D A, Khoury, S J, Weiner, H L

    Published in Annals of neurology (01-09-1997)
    “…Multiple sclerosis (MS) is postulated to be a Th1-type cell-mediated autoimmune disease. Thus therapies that decrease T cell interferon (IFN)-gamma production…”
    Get more information
    Journal Article
  10. 10

    Increased Interleukin 12 Production in Progressive Multiple Sclerosis: Induction by Activated CD4+ T Cells via CD40 Ligand by Balashov, Konstantin E., Smith, Derek R., Khoury, Samia J., Hafler, David A., Weiner, Howard L.

    “…Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system postulated to be a cell-mediated autoimmune disease in which interferon…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis by Windhagen, A., E. Anderson, D., Carrizosa, A., Balashov, K., L. Weiner, H., A. Hafler, D.

    Published in Journal of neuroimmunology (02-11-1998)
    “…The objective of this study was to determine whether autoreactive T cells in patients with multiple sclerosis (MS) are polarized and committed in their…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection by Pohl-Koppe, A, Balashov, K E, Steere, A C, Logigian, E L, Hafler, D A

    Published in The Journal of immunology (1950) (15-02-1998)
    “…A novel population of both IFN-gamma- and IL-10-secreting human T cells that differentiate in the presence of exogenous IL-12 in vitro has recently been…”
    Get full text
    Journal Article
  15. 15

    Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis by Balashov, K E, Khoury, S J, Hafler, D A, Weiner, H L

    Published in The Journal of clinical investigation (01-06-1995)
    “…The autologous mixed lymphocyte reaction (AMLR) involves the activation of T cells by autologous antigen presenting cells. Cells are generated during the…”
    Get full text
    Journal Article
  16. 16

    Application of anti-CD3-treated lymphocytes as stimulator cells in human autologous mixed lymphocyte cultures for generation of autorestricted CD8+ suppressor T cells by Balashov, K E, Brondz, B D

    Published in Immunology letters (15-02-1992)
    “…The purpose of the present study was to investigate the application of anti-CD3-treated lymphocytes as stimulator cells in human one-way autologous mixed…”
    Get more information
    Journal Article
  17. 17

    Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy by Comabella, M, Balashov, K, Issazadeh, S, Smith, D, Weiner, H L, Khoury, S J

    Published in The Journal of clinical investigation (15-08-1998)
    “…Multiple sclerosis is postulated to be a Th1-type cell-mediated autoimmune disease. We investigated cytokine profiles in patients with progressive multiple…”
    Get full text
    Journal Article
  18. 18

    Different conditions for generation of non-cytotoxic autorestricted CD4-CD8+ human suppressor T cells and allospecific cytotoxic T lymphocytes in one-way mixed lymphocyte cultures: the role of adherent mononuclear cells by Balashov, K E, Brondz, B D

    Published in Scandinavian journal of immunology (01-11-1991)
    “…The purpose of the present study was to investigate the role of adherent mononuclear cells (AMC) in generation of suppressor T lymphocytes (T-Lph) in one-way…”
    Get more information
    Journal Article
  19. 19
  20. 20

    The role of T lymphocytes in the immunotherapy of tumours by Brondz, B D, Balashov, K E

    Published in Biomedical science (1991)
    “…The interactions of tumour cells with membrane molecules of T-cell subsets, as well as methods directed towards the enhancement of antitumour immunity, are…”
    Get more information
    Journal Article